Atrás
Rango del Día
$7.61
$8.18
Rango de 52 Semanas
$6.66
$18.90
Volumen
1,869,456
Promedio 50D / 200D
$9.69
/
$11.76
Cierre Anterior
$7.54
Quick Summary
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (631 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -4.6 | 0.2 |
| P/B | 6.9 | 3.0 |
| ROE % | -92.3 | 3.6 |
| Net Margin % | -203.3 | 3.8 |
| Rev Growth 5Y % | 97.8 | 9.9 |
| D/E | 0.9 | 0.2 |
Precio Objetivo de Analistas
Hold
$29.33
+271.3%
Low: $26.00
High: $32.00
EPS Futuro
-$1.47
Ingresos Est.
160.28M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$1.72
$1.14 – $2.07
|
689.76M | 1 |
| FY2029 |
$1.11
$0.74 – $1.34
|
582.22M | 1 |
| FY2028 |
$0.20
-$0.92 – $0.82
|
427.81M | 5 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-09 | -$0.43 | -$0.42 | +2.3% |
| 2025-11-10 | -$0.45 | -$0.52 | -15.6% |
| 2025-08-13 | -$0.41 | -$0.46 | -12.2% |
| 2025-05-14 | -$0.35 | -$0.35 | 0.0% |
| 2025-03-20 | -$0.04 | $0.52 | +1400.0% |
| 2024-11-13 | -$0.18 | -$0.20 | -11.1% |
| 2024-08-06 | -$0.12 | -$0.13 | -8.3% |
| 2024-05-09 | -$0.11 | -$0.11 | 0.0% |
Insider Trading Activity
20 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 2, 2026 |
Dorsey Brian
Chief Operating Officer
|
grant | 240,000 | — | — |
| Jan 2, 2026 |
Chakma Justin
Chief Business Officer
|
grant | 240,000 | — | — |
| Jan 2, 2026 |
Scott Kathleen D.
Chief Financial Officer
|
grant | 240,000 | — | — |
| Jan 2, 2026 |
Lowenthal Richard E
PRESIDENT AND CEO
|
grant | 1,115,000 | — | — |
| Jan 2, 2026 |
Tanimoto Sarina
CHIEF MEDICAL OFFICER
|
grant | 1,115,000 | — | — |
| Nov 13, 2025 |
Dorsey Brian
Chief Operating Officer
|
other | 43,656 | $0.64 | — |
| Nov 13, 2025 |
Dorsey Brian
Chief Operating Officer
|
sell | 21,828 | $8.71 | $190,049.85 |
| Aug 21, 2025 |
Scott Kathleen D.
Chief Financial Officer
|
other | 25,000 | $1.50 | — |
| Aug 21, 2025 |
Scott Kathleen D.
Chief Financial Officer
|
sell | 12,500 | $15.00 | $187,500.00 |
| Jul 1, 2025 |
Karas Eric
Chief Commercial Officer
|
other | 30,000 | $1.50 | — |
| Jul 1, 2025 |
Karas Eric
Chief Commercial Officer
|
sell | 15,000 | $16.99 | $254,860.50 |
| Jun 25, 2025 |
Shawver Laura
|
grant | 30,000 | — | — |
| Jun 25, 2025 |
Islam Saqib
|
grant | 30,000 | — | — |
| Jun 25, 2025 |
Shah Pratik
|
grant | 30,000 | — | — |
| Jun 25, 2025 |
Dadoo Rajeev
|
grant | 30,000 | — | — |
| Jun 25, 2025 |
Kelly Michael
|
grant | 30,000 | — | — |
| Jun 25, 2025 |
SAUNDERS BRENT L
|
grant | 30,000 | — | — |
| Jun 18, 2025 |
Karas Eric
Chief Commercial Officer
|
other | 30,000 | $1.50 | — |
| Jun 18, 2025 |
Karas Eric
Chief Commercial Officer
|
sell | 15,000 | $16.00 | $240,000.00 |
| May 20, 2025 |
SAUNDERS BRENT L
|
other | 240,000 | $1.01 | — |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Puntos Clave
Revenue grew 97.80% annually over 5 years — strong growth
Earnings declined -2241.76% over the past year
Negative free cash flow of -171.21M
PEG of 0.00 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 103.26%
Capital efficient — spends only 0.40% of revenue on capex
Crecimiento
Revenue Growth (5Y)
97.80%
Revenue (1Y)-5.46%
Earnings (1Y)-2241.76%
FCF Growth (3Y)N/A
Calidad
Return on Equity
-92.33%
ROIC-63.72%
Net Margin-203.25%
Op. Margin-212.92%
Seguridad
Debt / Equity
0.85
Current Ratio7.28
Interest Coverage-69.05
Valoración
P/E Ratio
-4.58
Forward P/EN/A
P/B Ratio6.87
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -5.46% | Revenue Growth (3Y) | 5200.25% |
| Earnings Growth (1Y) | -2241.76% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 97.80% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 84.28M | Net Income (TTM) | -171.30M |
| ROE | -92.33% | ROA | -52.28% |
| Gross Margin | 75.77% | Operating Margin | -212.92% |
| Net Margin | -203.25% | Free Cash Flow (TTM) | -171.21M |
| ROIC | -63.72% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.85 | Current Ratio | 7.28 |
| Interest Coverage | -69.05 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -4.58 | Forward P/E | N/A |
| P/B Ratio | 6.87 | P/S Ratio | 9.31 |
| PEG Ratio | 0.00 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 4.89 | Fwd Earnings Yield | N/A |
| FCF Yield | -21.82% | ||
| Market Cap | 784.45M | Enterprise Value | 840.09M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 84.28M | 89.15M | 30,000.0 | 1.32M | 5.51M |
| Net Income | -171.30M | 8.00M | -54.37M | -34.68M | -20.24M |
| EPS (Diluted) | -1.74 | 0.08 | -0.57 | -0.87 | -0.70 |
| Gross Profit | 63.86M | 68.59M | 30,000.0 | 1.32M | 5.29M |
| Operating Income | -179.45M | -3.08M | -67.52M | -35.52M | -19.45M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 327.65M | 351.15M | 233.19M | 281.44M | 61.45M |
| Total Liabilities | 213.39M | 94.36M | 2.43M | 8.55M | 92.72M |
| Shareholders' Equity | 114.26M | 256.80M | 230.76M | 272.89M | -31.27M |
| Total Debt | 96.96M | 42,000.0 | 274,000.0 | 481,000.0 | 9.03M |
| Cash & Equivalents | 41.32M | 50.82M | 70.97M | 210.52M | 60.06M |
| Current Assets | 284.90M | 334.30M | 231.56M | 277.70M | 60.73M |
| Current Liabilities | 39.15M | 23.44M | 2.39M | 5.44M | 8.19M |